Financial Disclosure

CHARLOTTE – October 29, 2026 -- JELD-WEN Holding, Inc. (NYSE: JELD) has launched an exchange offer that would swap its 4.875% Senior Notes due 2027 for new first lien senior secured notes due 2031 and raise up to $410.2 million in new money, with holders of about 94.5% of the old notes already committed to tender.

Backstop commitments cover 70% of the old notes

Holders representing roughly 70.0% of the old notes have committed to buy their agreed share of the up to $410.2 million in New Notes at $1,000 per $1,000 principal amount. The commitment covers any portion that other eligible holders do not subscribe for or fail to fund. The new money issuance shrinks dollar-for-dollar to the extent lenders holding Existing Term Loans decline to sell in a concurrent Dutch auction.

TOKYO – October 29, 2026 -- The Global Health Innovative Technology (GHIT) Fund has committed about JPY 1.06 billion (USD 6.8 million) to nine R&D projects covering drugs, vaccines and diagnostics for malaria, neglected tropical diseases (NTDs) and emerging infectious diseases such as Ebola.

Trachoma rapid test receives JPY 450 million for clinical validation and launch

The largest single award, about JPY 450 million (USD 2.9 million), goes to a point-of-care rapid diagnostic test for trachoma. The project is led by Drugs and Diagnostics for Tropical Diseases, Medical & Biological Laboratories (MBL), The Carter Center and Big Eye Diagnostics, and has received GHIT support since 2024.

Hoboken – October 29, 2026 -- Xyte reported its largest quarter ever for new annual recurring revenue (ARR) in the three months ended September 30, with enterprise and enterprise-led activity accounting for 90% of new business.

Xyte's ARR rose 122% in the fiscal year ended June 30

The record September quarter followed a fiscal year in which the AI cloud platform's ARR grew 122% year over year. Xyte manages multi-vendor audiovisual (AV) and workplace devices. It said organizations are turning to the platform to run workplace technology across vendors and sites.

More system integrators than ever have also launched branded managed service platforms powered by Xyte. The company did not disclose absolute revenue figures or the number of dealers.

Lysaker – October 29, 2026 -- Aker BP reported third-quarter EBITDA of USD 3.4 billion and cash flow from operations of USD 2.4 billion, as higher sold volumes and strong realised prices lifted earnings.

Net profit reaches USD 986 million, aided by a USD 262 million impairment reversal

Net profit came in at USD 986 million, or USD 1.56 per share. The figure includes a positive after-tax effect of USD 262 million from an impairment reversal.

Net sold volumes were 396 mboepd, up five percent from the previous quarter. Net production was lower at 374 mboepd, which the company attributed to planned maintenance. Aker BP reiterated its full-year production guidance of 380-400 mboepd.

Aker BP holds leverage at 0.50 with USD 5.8 billion in available liquidity

The company described its financial position as robust. The board set a quarterly dividend of USD 0.6615 per share, payable on or about 12 November 2026.

SHANGHAI – – October 29, 2026 -- United Imaging Healthcare (688271.SH) reported revenue of RMB 10.58 billion for the first nine months of 2026, up 19.43% year-on-year, as overseas sales climbed 50.30% to RMB 3.00 billion.

R&D spending reaches 21.08% of revenue

The company invested RMB 2.23 billion in R&D over the nine months, equal to 21.08% of revenue and 0.14 percentage points higher than a year earlier. It employs 3,937 R&D staff. Cumulative R&D investment from 2022, the year of its public listing, through September 2026 totals RMB 10.50 billion.

Asia-Pacific revenue more than doubles, Europe grows nearly 30%

European revenue rose nearly 30% year-on-year in the period. Asia-Pacific revenue grew by more than 100% in Q1–Q3 2026, with progress in Singapore, Japan, South Korea, Australia and New Zealand.

SHANGHAI – October 29, 2026 -- United Imaging Healthcare (688271.SH) posted revenue of RMB 10.58 billion for the first nine months of 2026, up 19.43% year-on-year, as international sales grew 50.30%.

Third-quarter revenue reached RMB 3.53 billion. Net profit attributable to shareholders rose 13% year-on-year to RMB 138 million.

International sales reach 28.31% of group revenue

Overseas revenue totaled RMB 3.00 billion in the period. Its share of total revenue rose 5.82 percentage points from a year earlier to 28.31%.

Europe revenue grows nearly 30% on 850-plus deliveries

Cumulative deliveries in Europe exceeded 850 systems, with high-end imaging equipment deployed in more than half of EU member states. A regional team of more than 160 employees supports the business. In North America, the company expanded relationships with integrated delivery networks and secured eligibility under framework agreements.

Frankfurt – October 29, 2026 -- KfW IPEX-Bank has committed USD 300 million to a USD 1.5 billion untied loan for commodities trader Trafigura. The loan finances more than 150 TWh of natural gas deliveries to Germany over five years.

Nine-bank consortium backs facility with Euler Hermes guarantee

The financing is an untied financial loan (UFK) covered by a guarantee from German export credit insurer Euler Hermes. Nine banks participate. KfW IPEX-Bank acts as Facility Agent and as coordinator and agent for the export credit agency (ECA).

Trafigura to supply SEFE from its global gas portfolio

Trafigura will deliver the volumes to SEFE Securing Energy for Europe, drawing primarily on its global gas portfolio. The first delivery is scheduled for November 1, 2026.

The parties say the transaction is meant to offset declining gas supplies and to support supply security and the resilience of energy infrastructure in Germany and Europe.

Frankfurt – October 29, 2026 -- Nearly 36 percent of German mid-sized companies still rated bank behavior in credit negotiations as restrictive in the third quarter of 2026, almost five percentage points fewer than in the prior quarter, according to the KfW-ifo Credit Hurdle. Lending conditions are easing, but remain tighter than the average of recent years.

Large corporates see restrictive lending fall to 27 percent

Just over 27 percent of surveyed large companies reported restrictive lending behavior by their banks. That is almost six percentage points below the previous quarter. KfW compiles the indicator each quarter from ifo Institute business survey data, broken down by company size and economic sector.

PITTSBURGH – October 29, 2026 -- Wesco International reported record third-quarter net sales of $7.2 billion, up 17% year over year and 8% sequentially, and raised its full-year 2026 outlook as backlog grew about 80%.

Data center sales rise about 55% to $1.8 billion

Data center sales reached $1.8 billion, up roughly 55% from a year earlier. Non-data center sales rose 7%. Organic sales grew 16.6%, with volume gains in all three segments (CSS, EES and UBS) and a favorable price effect. Organic sales for the first nine months rose 13.9%.

Total company backlog hit a record, and each of the three business units set its own backlog record. CEO John Engel said the growth is fueled by multi-year customer commitments, and that the past five consecutive quarters of double-digit sales growth show a growth profile that extends beyond data centers.

Frankfurt am Main – October 29, 2026 -- Germany recorded 772 postmortem organ donors from January to September 2026, up 28 or 3.8% on the same period last year, the Deutsche Stiftung Organtransplantation (DSO) said at the opening of its 22nd Annual Congress.

Organs removed in Germany and allocated through Eurotransplant for transplantation at home or abroad totaled 2,373, compared with 2,258 a year earlier, a gain of 115 organs.

DSO says about 8,000 patients still wait for a donor organ

DSO Medical Director Dr. Axel Rahmel said the positive trend from last year continues but remains well short of what is needed for the roughly 8,000 people on German waiting lists. He cited the lack of a documented decision by potential donors as a key reason for low numbers. Most Germans view donation favorably, but few record that stance in writing, and the resulting uncertainty often leads relatives to refuse consent.